CDKN2A and breast cancer: We transplanted 1 × 106 cells from a p16−/−; Brca1MGKO mammary tumor, and 4 × 106 cells from a p16+/−; Brca1MGKO mammary tumor, respectively, into MFPs of NSG mice (three recipients per primary tumor).